Rates of arrhythmic events and death remained common in patients indicated for implantable cardioverter defibrillator or ...

The Food and Drug Administration (FDA) has cleared the Jewel ® Patch Wearable Cardioverter Defibrillator (Patch-WCD) for adult patients aged 18 years and older who are at risk for sudden cardiac ...

A system hybridizing cardiac contractility modulation and implantable cardioverter defibrillation successfully converted ...

Implantable cardioverter-defibrillator therapy in patients with Brugada syndrome is effective for prevention of fatal arrhythmias.

VENTRICULAR fibrillation is usually a rapidly fatal arrhythmia that may occur in cardiac patients, in any patient under anesthesia and in drowning and electrocution. In cardiac patients it is a ...

Ventricular fibrillation is a cardiac arrhythmia in which the muscle in the lower chambers of the heart (the ventricles) contracts irregularly and rapidly. The ventricles quiver and are unable to ...

Medtronic (NYSE: MDT) announced that it received FDA approval for its OmniaSecure defibrillation lead for right ventricle ...

Brenan Cullimore, a 28-year-old medical student, died of cardiac arrest after collapsing during a basketball game with ...

The biggest names in cardiac care gathered in San Diego for the Heart Rhythm Society (HRS) 2025 Annual Meeting.

The son of 62-year-old John William Cannon is suing American Airlines after his father was allegedly denied medical attention ...

Medtronic said its OmniaSecure device can be used to treat potentially life-threatening conditions including ventricular tachyarrhythmias, a heart rhythm disorder where the heart's lower chambers beat ...